0 (0%)		10-14 15:23
Open: High: Volume: 0		Pre. Close: Low: Market Cap: 0(M)

Short term
Mid term
Targets	6-month :	21.75	1-year :	21.97
Resists	First :	18.62	Second :	18.81
Pivot price	18.42
Supports	First :	18.31	Second :	15.24
MAs	MA(5) :	18.4	MA(20) :	18.5
	MA(100) :	18.73	MA(250) :	18.62
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	15.4	D(3) :	19.9
RSI	RSI(14): 29.8
52-week	High :	18.97	Low :	18.08

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ PTBD ] has closed above bottom band by 9.0%. Bollinger Bands are 2.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	18.44 - 18.55	18.55 - 18.64
Low:	18.13 - 18.25	18.25 - 18.36
Close:	18.24 - 18.43	18.43 - 18.6

Tue, 13 Oct 2026
(PTBD) Risk Channels and Responsive Allocation - Stock Traders Daily

Mon, 07 Sep 2026
S1606 Cost-Effectiveness Analysis of Endoscopic... : American Journal of Gastroenterology - Ovid

Wed, 29 Jul 2026
A Novel Approach to Palliative Bowel... : American Journal of Gastroenterology - Ovid

Tue, 19 May 2026
Assessment of Technical and Clinical Success of Percutaneous Transhepatic Biliary Drainage for Postoperative Bile Leaks: A Favorable Alternative to Early Surgical Revision? - Cureus

Thu, 16 Jan 2025
Prognostic factors for survival in patients with advanced cholangiocarcinoma treated with percutaneous transhepatic drainage - Nature

Wed, 26 Jun 2024
Improved Survival With Chemotherapy in Patients With Malignant Biliary Tract Obstruction After Percutaneous Transhepatic Biliary Drainage (PTBD) - Cureus

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange:
Sector:
Industry:
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.